Medical Devices Investors & VC Firms
1393 firms in this list, with a median first check of $500K. 266 of them lead rounds. Generated from verified public data and updated continuously.
Blue Ocean Capital Group
ShenzhenLate Stage
21 people
Venture Ontario
TorontoSeed–Growth
3 people
BRM Capital
Tel AvivSeed–Late Stage$1.7M – $28M
14 people
Endurance28
San FranciscoPre-Seed–Series A
14 people
Maverick Ventures Israel
Tel AvivSeed–Series B$2M – $5M
11 people
Amulet Capital Partners, LP
Greenwich
25 people
Sixty Degree Capital
North YorkPre-Seed–Late Stage
19 people
California Technology Ventures
PasadenaSeed–Late Stage$250K – $2M
3 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Late Stage
Vertex Ventures China
SingaporePre-Seed–Late Stage$2M – $85M
6 people
GSR United Capital
BeijingSeed–Late Stage$98K – $50M
Qbic Fund
St-Denijs-WestremPre-Seed–Series A
18 people
Talde Private Equity
MadridGrowth$3.2M – $10.8M
11 people
Necessary Ventures
San FranciscoPre-Seed–Late Stage$1M – $2M
10 people
Planven Entrepreneur Ventures
ZurichSeed–Late Stage$10M – $20M
18 people
TPG
San FranciscoGrowth–Late Stage
19 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
1 person
Limburgse Reconversie Maatschappij
HasseltSeed–Late Stage$27K – $10.8M
22 people
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Redmont Capital
BirminghamGrowth$1M – $10M
21 people
Sciety
StockholmSeed–Growth
21 people
XGEN Venture
MilanPre-Seed–Series A
21 people
Phaze Ventures
MuscatPre-Seed–Growth$1M – $22M
8 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.
































































